Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

502 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Residual disease detected by multidimensional flow cytometry shows prognostic significance in childhood acute myeloid leukemia with intermediate cytogenetics and negative FLT3-ITD: a report from the Tokyo Children's Cancer Study Group.
Keino D, Kinoshita A, Tomizawa D, Takahashi H, Ida K, Kurosawa H, Koike K, Ota S, Iwasaki N, Fujimura J, Yuza Y, Kiyotani C, Yamamoto S, Osumi T, Ueda T, Mochizuki S, Isoyama K, Hanada R, Tawa A, Manabe A, Toguchi Y, Ohara A. Keino D, et al. Among authors: ohara a. Int J Hematol. 2016 Apr;103(4):416-22. doi: 10.1007/s12185-016-1937-y. Epub 2016 Jan 18. Int J Hematol. 2016. PMID: 26781613 Clinical Trial.
Six months of maintenance chemotherapy after intensified treatment for acute lymphoblastic leukemia of childhood.
Toyoda Y, Manabe A, Tsuchida M, Hanada R, Ikuta K, Okimoto Y, Ohara A, Ohkawa Y, Mori T, Ishimoto K, Sato T, Kaneko T, Maeda M, Koike Ki, Shitara T, Hoshi Y, Hosoya R, Tsunematsu Y, Bessho F, Nakazawa S, Saito T. Toyoda Y, et al. Among authors: ohara a. J Clin Oncol. 2000 Apr;18(7):1508-16. doi: 10.1200/JCO.2000.18.7.1508. J Clin Oncol. 2000. PMID: 10735899 Clinical Trial.
An effective chemotherapeutic regimen for acute myeloid leukemia and myelodysplastic syndrome in children with Down's syndrome.
Kojima S, Sako M, Kato K, Hosoi G, Sato T, Ohara A, Koike K, Okimoto Y, Nishimura S, Akiyama Y, Yoshikawa T, Ishii E, Okamura J, Yazaki M, Hayashi Y, Eguchi M, Tsukimoto I, Ueda K. Kojima S, et al. Among authors: ohara a. Leukemia. 2000 May;14(5):786-91. doi: 10.1038/sj.leu.2401754. Leukemia. 2000. PMID: 10803507 Clinical Trial.
Delay of the diagnostic lumbar puncture and intrathecal chemotherapy in children with acute lymphoblastic leukemia who undergo routine corticosteroid testing: Tokyo Children's Cancer Study Group study L89-12.
Manabe A, Tsuchida M, Hanada R, Ikuta K, Toyoda Y, Okimoto Y, Ishimoto K, Okawa H, Ohara A, Kaneko T, Koike K, Sato T, Sugita K, Bessho F, Hoshi Y, Maeda M, Kinoshita A, Saito T, Tsunematsu Y, Nakazawa S. Manabe A, et al. Among authors: ohara a. J Clin Oncol. 2001 Jul 1;19(13):3182-7. doi: 10.1200/JCO.2001.19.13.3182. J Clin Oncol. 2001. PMID: 11432884
Myelodysplastic syndrome in childhood: a retrospective study of 189 patients in Japan.
Sasaki H, Manabe A, Kojima S, Tsuchida M, Hayashi Y, Ikuta K, Okamura I, Koike K, Ohara A, Ishii E, Komada Y, Hibi S, Nakahata T; MDS Committee of the Japanese Society of Pediatric Hematology, Japan. Sasaki H, et al. Among authors: ohara a. Leukemia. 2001 Nov;15(11):1713-20. doi: 10.1038/sj.leu.2402271. Leukemia. 2001. PMID: 11681412
Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children.
Kojima S, Ohara A, Tsuchida M, Kudoh T, Hanada R, Okimoto Y, Kaneko T, Takano T, Ikuta K, Tsukimoto I; Japan Childhood Aplastic Anemia Study Group. Kojima S, et al. Among authors: ohara a. Blood. 2002 Aug 1;100(3):786-90. doi: 10.1182/blood.v100.3.786. Blood. 2002. PMID: 12130487 Free article. Clinical Trial.
Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation.
Kosaka Y, Koh K, Kinukawa N, Wakazono Y, Isoyama K, Oda T, Hayashi Y, Ohta S, Moritake H, Oda M, Nagatoshi Y, Kigasawa H, Ishida Y, Ohara A, Hanada R, Sako M, Sato T, Mizutani S, Horibe K, Ishii E. Kosaka Y, et al. Among authors: ohara a. Blood. 2004 Dec 1;104(12):3527-34. doi: 10.1182/blood-2004-04-1390. Epub 2004 Aug 5. Blood. 2004. PMID: 15297313 Free article. Clinical Trial.
No advantage of dexamethasone over prednisolone for the outcome of standard- and intermediate-risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study Group L95-14 protocol.
Igarashi S, Manabe A, Ohara A, Kumagai M, Saito T, Okimoto Y, Kamijo T, Isoyama K, Kajiwara M, Sotomatsu M, Sugita K, Sugita K, Maeda M, Yabe H, Kinoshita A, Kaneko T, Hayashi Y, Ikuta K, Hanada R, Tsuchida M. Igarashi S, et al. Among authors: ohara a. J Clin Oncol. 2005 Sep 20;23(27):6489-98. doi: 10.1200/JCO.2005.01.982. J Clin Oncol. 2005. PMID: 16170158 Clinical Trial.
Survival outcome after the first central nervous system relapse in children with acute lymphoblastic leukemia: a retrospective analysis of 79 patients in a joint program involving the experience of three Japanese study groups.
Tsurusawa M, Yumura-Yagi K, Ohara A, Hara J, Katano N, Tsuchida M; Japanese Study Groups. Tsurusawa M, et al. Among authors: ohara a. Int J Hematol. 2007 Jan;85(1):36-40. doi: 10.1532/IJH97.06085. Int J Hematol. 2007. PMID: 17261500
502 results